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1. Classification of drugs
Drugs are classified into “over‐the‐counter (OTC) drugs” that are sold in drug stores and “medicinal 
(or ethical) drugs” that are prescribed by doctors [1] (Figure 1). “Herbal drug materials” and “Kampo 
(Japanese Traditional Medicines)” belong to OTC drugs, whereas new drugs and generics belong to 
the medicinal drugs. In contrast to Western medicines that recognize the drug as single compounds, 
Kampo medicines are a mixture of more than two components of herbal extracts. Pharmacopeia 
17th edition accommodates a total of 323 herbal medicines (33 Kampo medicine + 290 herbal drug 
materials/formulations). Licorice is a crude drug prescribed in various herbal formulas in traditional 
Japanese and Chinese medicines and also used worldwide as a food natural sweetener. The origin 
of licorice was the root or stolon of Glycyrrhiza uralensis or G. glabra (Legminosae) [1]. Licorice con‐
tains three orders higher amounts of glycyrrhizin, as compared with other components [2].
Figure 1. Classification of drugs.
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2. Difference of Kampo medicine and Western medicine
To select the best Kampo medicine, the patient's condition will be first checked by the crite‐
ria of yin‐yang and xu‐shi categorization (activity and physical fitness) and then narrowed 
down by the life force, blood and colorless bodily fluids, (if necessary) followed by the five 
viscera theory and the pulse, tongue and belly (Figure 2). As compared with Western medi‐
cine, Kampo medicine is more empirical (rather than scientific), comprehensive (rather than 
analytical), global (rather than local) and personal (rather than general) and normalizes the 
patient's condition (rather than removing the cause of disease).
During the business sorting work in 2009, the then Japanese regime proposed the exemp‐
tion of insurance against Kampo medicines, fomentations and mouth washes, claiming that 
Kampo medicine is evidence less and it can be obtained very easily by anybody. However, 
the patients, herbalists and medical personnel moved against this proposal by means of col‐
lecting approximately one million signatures and made the proposal withdrawn. Now, in 
Japan, approximately 150 Kampo medicines and 200 herbal drugs used as decoctions are 
covered by health insurance. Among the 900 physicians who worked in the core cancer treat‐
ment hospitals, 92.4% reported having prescribed Kampo medications [3]. Nationwide, ran‐
dom‐sampled and population‐weighted telephone survey demonstrated that respondents 
who had used at least one complementary and alternative medicine (CAM) therapy (76.0%) 
were greater than those who had used orthodox Western medicine (65.6%) and that the 
expenditure for CAM was nearly half that of orthodox Western medicine [4]. The most com‐
mon CAM practice was Kampo, which corresponded to 96.1% of CAM‐practicing doctors 
[5]. However, it still remains to be clarified why the Kampo medicines exert beneficial effects 
on our body.
Figure 2. Process of grasping the patient's condition prior to the prescriptions of drugs.
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3. Application of Kampo medicines
Kampo medicines have been used to improve the symptoms of various diseases (Table 1). 
Bakumondoto, Hochuekkito and Kiyoshihaiyu, which contains licorice, have been reported to 
improve the symptoms of chronic obstructive pulmonary disease (COPD) [6, 7]. Daikenchuto 
(that contains hydroxy‐α‐sanshool and 6‐shogaol as major ingredients) improved the intesti‐
nal motor paralysis and Crohn's disease, by increasing the RAMP (receptor activity‐modify‐
ing membrane protein) 1, 2, 3, mobilizing the CGRP (calcitonin gene‐related peptide) and 
AMD (adrenomedullin) and inhibiting the expression of pro‐inflammatory cytokines (TNF‐α, 
IFN‐γ) [8]. Rikkunshito recovered the meal uptake by increasing the plasma des‐acyl ghrelin 
level, suggesting its possible application to dyspepsia [9].
Old people experience the decline of body strength and vital function, the continuous languor, 
the loss of appetite and the fatigability. This kind of aging‐associated characteristics cannot be 
remedied by Western medicines, but more easily alleviated by treating with co‐agents such as 
Hochuekkito and Juzentaihoto. However, licorice present therein may induce hypokalemia 
Used to treat or improve the symptom of: Presence of 
Licorice
Bakumondoto Chronic obstructive pulmonary disease (COPD)
Bofutsushosan Insulin resistance, obesity
Daikenchuto Increase in intestinal blood flow, Crohn's disease
Goreisan Migraine
Hachimijiogan Arteriosclerosis, dysuria, prostatomegaly
Hangekobokuto Depression
Hochuekkito COPD, depression
Juzentaihoto Hepatic fibrosis, carcinogenesis
Kakkonto Migraine
Keishibukuryogan Oxidant stress, vascular endothelial damage in patient arthritis, acne
Kiyoshihaiyu COPD
Maoto Inhibition of neuraminidase
Rikkunshito Functional‐dyspepsia, gastroesophageal reflux disease, depression
Saikokaryukotsuboreito Depression
Shosaikoto Hepatic fibrosis, carcinogenesis
Shoseiryuto Allergic rhinitis
Tokishigyakukashokyoto Sensitivity to cold, numbness
Yokukansan Dementia
Table 1. Application of Kampo medicines to various diseases.
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(hypertension, edema, feeling of weakness, convulsions paralysis of the extremities, arrhyth‐
mia) [10]. Shosaikoto, which also contains licorice, is known to induce interstitial pneumonia 
(fever, dry cough, exertional dyspnea) [11]. The use of herbal medicines is increasing all over 
the world and when a patient with such risk factors is prescribed an herbal medicine con‐
taining licorice, careful follow‐up is required. The patient's symptoms should be carefully 
monitored and if no improvement in symptoms is observed, continuous treatment should be 
avoided.
4. Application to oral diseases
Oral cares are important to maintain the normal oral functions and prevent oral diseases. 
Recent report suggests an association between oral health and the risk of lacunar infarction 
[12]. Tooth‐blushing and myofunctional therapy stimulate the secretion of saliva [13, 14]. 
Mouthrinsing with aqueous biocompatible 2‐methacryloyloxyethyl phosphorylcholine 
(MPC)‐polymer inhibited the increase in oral bacterial numbers, especially of S. mutans [15]. 
The inhibition of bacterial adherence and biofilm development may prevent the aspiration 
pneumonia and the periodontitis [16].
However, if the extent of oral diseases exceeds the capacity of oral care, we have to rely on 
medicines. Various Kampo medicines are used to treat oral diseases such as stomatitis, xero‐
stomia, taste disturbance, halitosis, glossodynia, temporomandibular joint and muscle disor‐
ders (TMJ), tooth extraction and periodontal disease (Table 2).
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Bakumondoto ● ● ●
Byakkokaninjinto ● ● ● ●
Daisaikoto ●  
Goreisan ● ● ● ●  
Hachimijiogan ●
Hangekobokuto ● ● ● ● ●
Hangeshoshinto ● ● ● ●
Hochuekkito ● ● ● ●
Inchinkoto ●  
Jiinkokato ●  
Jumihaidokuto ●
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Hangeshashashashinto showed anti‐inflammatory [17], oral ulcer‐induced pain‐releasing 
[18], antimicrobial [19], antimucositis [20] and antioxidative activities [21]. Orento prevented 
the inflammatory responses in lipopolysaccharide‐treated human gingival fibroblasts [22]. 
Rikkosan also induced anti‐inflammatory activity [17]. Shosaikoto showed anti‐inflammatory 
[23] and anti‐hyperlipidemic and anti‐atherosclerotic activities [24]. It should be noted that all 
these four Kampo medicines contain licorice (Table 2).
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Juzentaihoto ● ● ● ●  
Kakkonto ● ●  
Kamishoyosan ● ● ● ● ●  
Kanbakutaisoto ●  
Keishikajutsubuto ● ● ● ●  
Keishibukuryogan ●  
Kikyoto ●  
Kososan ●
Orengedokuto ● ● ● ●  
Orento ● ● ●  
Rikkosan ● ● ●
Rikkunshito ● ● ● ● ●  
Saibokuto ● ● ●  
Saikokaryukotsuboreito ● ● ●  
Saikokeishikankyoto ●  
Saikokeishito ●
Saireito ● ●  
Seishinrenshiin ●  
Shakuyakukanzoto ●  
Shosaikoto ● ● ● ●  
Sokeikakketsuto ●  
Tokishakuyakusan ● ●  
Unseiin ● ●  
Table 2. Application of Kampo medicines to oral diseases.
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Kampo medicines are also effective to alleviate the glossodynia [25] and cancer thermother‐
apy‐induced side effects [26–28].
5. Future direction
We sometimes experience that purification of active ingredients leads to significant loss of 
the biological activity. Furthermore, the amount of ingredients is different from one batch to 
another depending on where they are harvested. Therefore, it is essential to reconstruct the 
best sets of active ingredients for the standardization of the contents. First step to accomplish 
this is to investigate the relationship between the biological activity of structurally related com‐
pounds and chemical descriptors, using quantitative structure‐activity relationship (QSAR) 
analysis. Once the best 3D structure is predicted, such compounds should be quickly synthe‐
sized to confirm its biological activity. This process is repeated until the satisfactory results are 
obtained. The next step is to determine the best combination of ingredients (Figure 3).
The relative potency of ingredients may depend on the type of target cells. For example, 
licorice flavonoids showed potent anti‐HSV activity, while they were inactive against HIV 
infection [29]. During isolation of active ingredients, some aggregations between ingredients 
may happen [30]. Accumulation and analysis of such data are crucial to manufacture the best 
Kampo medicine.
Using QASR analysis, we recently found that anti‐HSV activity of 19 flavonoids including 10 
licorice flavonoids correlated well with six chemical descriptors that represent polarizability 
Figure 3. Chart flow to select the best combination of licorice ingredients. Each symbol is any compound.  The same 
shapes indicated the compounds with similar structure.
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(MATS5p, GATS5p), ionization potential (GATS5i), number of ring systems (NRS), atomic 
number (J_Dz(Z)) and mass (J_Dz(m) (p < 0.0001). This result suggests that the physico‐
chemical properties, rather than the category of compound, are important factors in deter‐
mining the anti‐HSV activity [29]. The possibility that their target site may be common is 
under investigation.
It is expected that in the future, alternative therapy with Kampo medicines will be versioned 
up, in synchronization with the improvement in the personalized medicine based on the gene 
information.
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